Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in japanese patients with acute ischemic stroke

Cerebrovascular Diseases

Volumn 36, Issue 5-6, 2013, Pages 388-393

  Suda, Satoshi ^a   Katsumata, Toshiya ^a   Okubo, Seiji ^a   Kanamaru, Takuya ^a   Suzuki, Kentaro ^a   Watanabe, Yoko ^a   Katsura, Ken Ichiro ^a   Katayama, Yasuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Eicosapentaenoic acid; Neurological deterioration; Polyunsaturated fatty acid; Stroke

Indexed keywords

ARACHIDONIC ACID; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; N 6 POLYUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD EXAMINATION; BRAIN ISCHEMIA; COMORBIDITY; DETERIORATION; DIABETES MELLITUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGICAL DETERIORATION; PRIORITY JOURNAL; RANK SUM TEST; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; BRAIN REGION; CAPILLARY GAS CHROMATOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FATTY ACID BLOOD LEVEL; JAPANESE (PEOPLE); MENTAL DETERIORATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84890915788     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000355683     Document Type: Article

References (38)

1. Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K: Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry. Cerebrovasc Dis 2012; 34: 140-146
2. Thanvi B, Treadwell S, Robinson T: Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J 2008; 84: 412-417
3. Lin LC, Lee TH, Chang CH, Chang YJ, Liou CW, Chang KC, Lee JD, Peng TY, Chung J, Chen SC, Yang JT: Predictors of clinical deterioration during hospitalization following acute ischemic stroke. Eur Neurol 2012; 67: 186-192
4. Rodriguez-Yanez M, Castellanos M, Blanco M, Garcia MM, Nombela F, Serena J, Leira R, Lizasoain I, Davalos A, Castillo J: New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology 2006; 67: 1973-1978 (Pubitemid 44967373)
5. Serena J, Rodriguez-Yanez M, Castellanos M: Deterioration in acute ischemic stroke as the target for neuroprotection. Cerebrovasc Dis 2006; 21(suppl 2):80-88
6. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Goldbourt U, Greenland P: Fish consumption and incidence of stroke: a metaanalysis of cohort studies. Stroke 2004; 35: 1538-1542 (Pubitemid 38823619)
7. Iso H, Rexrode KM, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Hennekens CH, Willett WC: Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001; 285: 304-312 (Pubitemid 32095033)
8. Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-1209 (Pubitemid 15009153)
9. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JT: Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Circulation 2000; 102: 2677-2679
10. Tanaka K, Ishikawa Y, Yokoyama M, Origasa H, Matsuzaki M, Saito Y, Matsuzawa Y, Sasaki J, Oikawa S, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K: Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke 2008; 39: 2052-2058
11. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003; 361: 477-485 (Pubitemid 36173713)
12. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR: Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-Analysis. BMJ 2013; 346:e8707
13. King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, Michael-Titus AT: Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 2006; 26: 4672-4680 (Pubitemid 44315368)
14. Katayama Y, Katsumata T, Muramatsu H, Usuda K, Obo R, Terashi A: Effect of longterm administration of ethyl eicosapentate (EPA-E) on local cerebral blood flow and glucose utilization in stroke-prone spontaneously hypertensive rats (SHRSP). Brain Res 1997; 761: 300-305 (Pubitemid 27305990)
15. Ueda M, Inaba T, Nito C, Kamiya N, Katayama Y: Therapeutic impact of eicosapentaenoic acid on ischemic brain damage following transient focal cerebral ischemia in rats. Brain Res 2013; 1519: 95-104
16. Ajami M, Eghtesadi S, Razaz JM, Kalantari N, Habibey R, Nilforoushzadeh MA, Zarrindast M, Pazoki-Toroudi H: Expression of Bcl-2 and Bax after hippocampal ischemia in DHA + EPA treated rats. Neurol Sci 2011; 32: 811-818
17. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41 (Pubitemid 23014379)
18. Ishiguro J, Tada T, Ogihara T, Ohzawa N, Murakami K, Kosuzume H: Metabolic disposition of ethyl eicosapentaenoate and its metabolites in rats and dogs. J Pharmacobiodyn 1988; 11: 251-261
19. Hirai A, Hamazaki T, Terano T, Nishikawa T, Tamura Y, Kamugai A, Jajiki J: Eicosapentaenoic acid and platelet function in Japanese. Lancet 1980; 2: 1132-1133 (Pubitemid 11240739)
20. Mishina M, Kim K, Kominami S, Mizunari T, Kobayashi S, Katayama Y: Impact of polyunsaturated fatty acid consumption prior to ischemic stroke. Acta Neurol Scand 2013; 127: 181-185
21. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351-356 (Pubitemid 17104996)
22. Yamamoto H, Bogousslavsky J, van Melle G: Different predictors of neurological worsening in different causes of stroke. Arch Neurol 1998; 55: 481-486 (Pubitemid 28182693)
23. Tei H, Uchiyama S, Ohara K, Kobayashi M, Uchiyama Y, Fukuzawa M: Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 2000; 31: 2049-2054
24. Adams HP Jr., Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD: Baseline NIH stroke scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53: 126-131 (Pubitemid 29329660)
25. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ: Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 1999; 30: 1208-1212 (Pubitemid 29259175)
26. Barber M, Wright F, Stott DJ, Langhorne P: Predictors of early neurological deterioration after ischaemic stroke: a case-control study. Gerontology 2004; 50: 102-109 (Pubitemid 38223786)
27. Kamada H, Yu F, Nito C, Chan PH: Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction. Stroke 2007; 38: 1044-1049 (Pubitemid 46568472)
28. Katsura K, Kristian T, Smith ML, Siesjo BK: Acidosis induced by hypercapnia exaggerates ischemic brain damage. J Cereb Blood Flow Metab 1994; 14: 243-250 (Pubitemid 24064437)
29. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G: Persistent inflammatory response in stroke survivors. Neurology 1998; 50: 1722-1728 (Pubitemid 28283241)
30. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR: C-reactive protein and outcome after ischemic stroke. Stroke 1999; 30: 981-985 (Pubitemid 29211614)
31. Seo WK, Seok HY, Kim JH, Park MH, Yu SW, Oh K, Koh SB, Park KW: C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. J Stroke Cerebrovasc Dis 2012; 21: 181-186
32. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J: Creactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-Analysis. Lancet 2010; 375: 132-140
33. Tapiero H, Ba GN, Couvreur P, Tew KD: Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother 2002; 56: 215-222 (Pubitemid 35245217)
34. Belayev L, Khoutorova L, Atkins KD, Bazan NG: Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia. Stroke 2009; 40: 3121-3126
35. Huang WL, King VR, Curran OE, Dyall SC, Ward RE, Lal N, Priestley JV, Michael-Titus AT: A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 2007; 130: 3004-3019 (Pubitemid 350033967)
36. Lim SN, Huang W, Hall JC, Ward RE, Priestley JV, Michael-Titus AT: The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats. Prostaglandins Leukot Essent Fatty Acids 2010; 83: 193-201
37. Mills JD, Bailes JE, Sedney CL, Hutchins H, Sears B: Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J Neurosurg 2011; 114: 77-84
38. Sun Q, Ma J, Campos H, Hankinson SE, Hu FB: Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in us women. Am J Clin Nutr 2007; 86: 74-81. (Pubitemid 47041595)